Evidence map›Paper›PMID 39817504›Full record

ArticleJournal of the American Heart Association2025

Number of Previous Strokes and the Association With Clinical Outcomes of Patients With Atrial Fibrillation: Longitudinal Data From the GLORIA-AF Registry.

Steven Ho Man Lam, Giulio Francesco Romiti, Bernadette Corica, Tommaso Bucci, Brian Olshansky, Tze-Fan Chao, Menno V Huisman, Gregory Y H Lip, GLORIA‐AF Investigators

Abstract readMulticenter Study
In one paragraph

Article in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Steven Ho Man LamLiverpool Centre for Cardiovascular Sciences at University of Liverpool Liverpool John Moores University and Liverpool Heart & Chest Hospital Liverpool UK.ORCID 0000-0003-2147-0995
Giulio Francesco RomitiLiverpool Centre for Cardiovascular Sciences at University of Liverpool Liverpool John Moores University and Liverpool Heart & Chest Hospital Liverpool UK.ORCID 0000-0002-3788-8942
Bernadette CoricaLiverpool Centre for Cardiovascular Sciences at University of Liverpool Liverpool John Moores University and Liverpool Heart & Chest Hospital Liverpool UK.ORCID 0000-0001-9460-4435
Tommaso BucciLiverpool Centre for Cardiovascular Sciences at University of Liverpool Liverpool John Moores University and Liverpool Heart & Chest Hospital Liverpool UK.ORCID 0000-0003-2895-6234
Brian OlshanskyDivision of Cardiology, Department of Medicine University of Iowa Iowa City IA USA.ORCID 0000-0002-6044-045X
Tze-Fan ChaoDivision of Cardiology, Department of Medicine Taipei Veterans General Hospital Taipei Taiwan.ORCID 0000-0002-6587-3094
Menno V HuismanDepartment of Thrombosis and Hemostasis Leiden University Medical Center Leiden the Netherlands.ORCID 0000-0003-1423-5348
Gregory Y H LipLiverpool Centre for Cardiovascular Sciences at University of Liverpool Liverpool John Moores University and Liverpool Heart & Chest Hospital Liverpool UK.ORCID 0000-0002-7566-1626
GLORIA‐AF Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with atrial fibrillation (AF) who suffered a previous stroke are at increased risk of recurrent thromboembolic events and other major outcomes. The impact of the number of stroke episodes on the natural history of patients with AF is still unclear. METHODS AND

resultsUsing data from the international, multicenter, and prospective GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation) Registry Phase III, we categorized patients with a recent diagnosis of non-valvular AF according to the number of previous strokes (either 0, 1, or ≥2 episodes). We analyzed use of oral anticoagulants through multiple logistic regression model, and risk of major outcomes using multiple Cox-regression models; our primary outcome was all-cause death. Among 21 223 patients (mean age: 70.2±10.3 years; 44.9% female) included, 2251 (10.6%) had a previous history of stroke, and 216 (1.0%) had ≥2 or more strokes. Oral anticoagulants were used in ≥80% of patients regardless of the numbers of previous stroke, although those with 1 (versus >1) prior stroke showed lower odds of receiving oral anticoagulants (odds ratio [95% CI]: 0.83 [0.73-0.94]). During 3-years follow-up, the risk of all-cause mortality increased with the number of previous strokes (hazard ratio [95% CI]: 1.46 [1.28-1.67] and 2.43 [1.79-3.29] for 1 versus 0 and ≥2 versus 0 previous strokes, respectively). Similar results were observed for other secondary outcomes, including thromboembolism, but not for major bleeding.

conclusionsHistory of stroke still represents a key risk factor in patients with AF. Patients who suffered more than 1 episodes of stroke had significantly worse prognosis and further efforts may be required to improve their clinical outcomes.

Indexed as

AnticoagulantsAtrial FibrillationStrokeAdministration, OralAgedAged, 80 and overCause of DeathFemaleHumansLongitudinal StudiesMaleMiddle AgedProspective StudiesRecurrenceRegistriesRisk AssessmentAnticoagulantsatrial fibrillationcardiovascular risknumber of stroke events

Identifiers

PMID39817504
PMCPMC12054405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.